Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Gluz

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Breast Care (Basel, Switzerland)|June 19, 2024
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024Marc Thill, Wolfgang Janni, Ute-Susann Albert, et al.
Breast Care (Basel, Switzerland)|June 4, 2026
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026Marc Thill, Volkmar Müller, Tanja Fehm, et al.
Breast Care (Basel, Switzerland)|April 16, 2025
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2025
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025Marc Thill, Wolfgang Janni, Ute-Susann Albert, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Breast Care (Basel, Switzerland)|June 19, 2024
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024Marc Thill, Wolfgang Janni, Ute-Susann Albert, et al.
Breast Care (Basel, Switzerland)|June 4, 2026
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026Marc Thill, Volkmar Müller, Tanja Fehm, et al.
Breast Care (Basel, Switzerland)|April 16, 2025
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2025
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025Marc Thill, Wolfgang Janni, Ute-Susann Albert, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Pageof 10